What's breaking now, across thousands of outlets.
Celldex said its experimental treatment barzolvolimab hit its primary endpoint in two Phase 3 trials, even as the readout raised safety concerns on two life-threatening cases of allergic reaction following administration of the drug. The ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Drugs Controller General of India advises that all non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics must be sold and distributed only on the prescription of a registered medical…
Plus news about Boehringer, Envisagenics, Ionis, Otsuka, Merck, Lexeo and Mantle. Amgen gets a win from Horizon buyout: Amgen said dazodalibep, a CD40 ligand antagonist, succeeded in a Phase ...
[New Era] Namibia is currently grappling with an acute shortage of 330 regional social workers, including community liaison officers, administrative officers and support staff, to help deliver…
(MedPage Today) -- Cardiologists Ronald Karlsberg, MD, and Venkatesh Murthy, MD, PhD, are among the new appointees to the U.S. Preventive Services Task Force (USPSTF).
Long-term research finds most children recovered from the effects of the pandemic.
Type 1 diabetes isn't an overnight attack against the body's ability to make insulin. It can be a sustained campaign over years that relentlessly targets insulin-producing cells in the pancreas.
